Development of a Human iPSC Cardiomyocyte-Based Scoring System for Cardiac Hazard Identification in Early Drug Safety De-risking

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have emerged as a promising cardiac safety platform, demonstrated by numerous validation studies using drugs with known cardiac adverse effects in humans. However, the challenge remains to implement hiPSC-CMs into cardiac de-risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Kopljar, Ivan, Lu, Hua Rong, Van Ammel, Karel, Otava, Martin, Tekle, Fetene, Teisman, Ard, Gallacher, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294263/
https://www.ncbi.nlm.nih.gov/pubmed/30540961
http://dx.doi.org/10.1016/j.stemcr.2018.11.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294263/
https://www.ncbi.nlm.nih.gov/pubmed/30540961
http://dx.doi.org/10.1016/j.stemcr.2018.11.007

Ejemplares similares